Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Modified Process Hepatitis B Vaccine in Healthy Infants
NCT00414050Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2006
- Primary completion
- Oct 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Merck & Co.. Started Oct 2006; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00414050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414050.